stars 1 stars 2 stars 3

Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting SK ion channels.

Acesion Pharma Questions

The Acesion Pharma annual revenue was $1 million in 2026.

Anders Holst is the CEO of Acesion Pharma.

13 people are employed at Acesion Pharma.

Acesion Pharma is based in Ballerup, Region Hovedstaden.

The NAICS codes for Acesion Pharma are [325, 3254, 32, 32541].

The SIC codes for Acesion Pharma are [2834, 28, 283].

Top Acesion Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users